Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05971420
Other study ID # USQ AEC H21REA071
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2021
Est. completion date January 15, 2022

Study information

Verified date July 2023
Source University of Southern Queensland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Using a Virtual Reality (VR) games-based application is as an innovative falls prevention technology in an aged care service. The VR intervention has promising effects on improving the physical and balance performances in the older adults.The study explored and evaluated the effects of VR activity-based training on falls prevention among community-dwelling older adults with mild cognitive impairment.


Description:

A pilot randomized control trial study was applied to compare the effects on falls prevention between participants who experienced a full-immersive VR training and group-based exercise (Baduanjin) training. Eighteen participants were recruited from ausing convenience sampling and were randomly assigned into the VR group and the exercise group (non-VR). The participants in both wo groups' participants attended 16 falls prevention training sessions over eight weeks. Eligible participants identified with a higher risk of mild cognitive impairment and early dementia undertook three measurements, pretest (T1), post-test (T2) and follow up (T3). The primary outcomes assessed included changes in physical risks factor of falls, and the secondary outcomes assessed included changes in cognition and fall efficacy.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date January 15, 2022
Est. primary completion date December 30, 2021
Accepts healthy volunteers No
Gender All
Age group 65 Years to 85 Years
Eligibility Inclusion Criteria: 1. aged 65 years to 85 years inclusive; 2. had a history of a fall within the past 2 years; 3. community-dwelling older adults; 4. at a higher risk of mild cognitive impairment and dementia, assessed by a validated screening tool of Hong Kong Montreal Cognitive assessment test (HK-MoCA score=21/22); 5. walk independently e.g. able to access publicly - VR research center centre or local community aged care facilities. Exclusion Criteria: if they had a medical diagnosis of unstable health conditions 1. dizziness; 2. Meniere's disease; 3. Epilepsy; 4. Parkinson's disease; 5. Severe hearing impairment and visual impairments; 6. Mental illness.

Study Design


Intervention

Other:
VR activity-based
VR games activities were chosen for simulated cognitive-motor training in the VR group. The VR training modules for this study included fire drill, walking exercise, balancing game activities and community shopping practices. These training modules involved dual task components; the participant was expected to train up his/her physical and cognitive motor performances in an 8-week VR activity-based program. VR group participants received 2-sessions per week, 16 training sessions in total.
Exercise-based (Baduanjin)
The exercise group used a traditional Chinese Qigong Baduanjin exercise incorporating with a fall prevention education strategy.

Locations

Country Name City State
Hong Kong The Hong Kong Polytechnic University, St. James Settlement Hong Kong, Salvation Army Hong Kong Hong Kong China

Sponsors (2)

Lead Sponsor Collaborator
University of Southern Queensland The Hong Kong Polytechnic University

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Berg balance test (BBS) - change is being assessed To test the balance performance and assess the fall risk. Total score is 56 ( score below 51 indicated predictive of fall risk) At prettest, postest (up to 8 weeks) and post 3 months follow up
Primary Time up and go test (TUG) - change is being assessed To assess functional mobility and assess the fall risk. Score over 12 seconds indicates higher risk of fall for the older adults At prettest, postest (up to 8 weeks) and post 3 months follow up
Primary Six minutes walk test (6MWT) - change is being assessed To assess the walking speed and performance. Walking distance within 6 minutes measured the length (m/metre) At prettest, postest (up to 8 weeks) and post 3 months follow up
Secondary Cognitive status assessed by Montreal Cognitive Assessment Scale- change is being assessed To assess the cognitive level. Total score 30 ( score if less than 22 indicated higher risk of midl cognitive impairment At prettest, postest (up to 8 weeks) and post 3 months follow up
Secondary Executive functioning tests by Trail making test A and test B *TMTA/B) - change is being assessed To assess the level of executive functions. It indicated the time of completion (second) At prettest, postest (up to 8 weeks) and post 3 months follow up
Secondary Fall efficacy by fall efficacy international scale (FESI) - change is being assessed To assess the level of fear concern. Totoal score is 64 (score lower than 27 indicated less fear concern At prettest, postest (up to 8 weeks) and post 3 months follow up
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A